113 related articles for article (PubMed ID: 35354150)
1. DNA Methylation-Mediated Lowly Expressed AOX1 Promotes Cell Migration and Invasion of Prostate Cancer.
Wu J; Wei Y; Li T; Lin L; Yang Z; Ye L
Urol Int; 2023; 107(5):517-525. PubMed ID: 35354150
[TBL] [Abstract][Full Text] [Related]
2. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133.
Zhang W; Chai W; Zhu Z; Li X
Int Immunopharmacol; 2020 Aug; 85():106618. PubMed ID: 32470878
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation in the promoter region inhibits AJAP1 expression and activates the JAK/STAT pathway to promote prostate cancer cell migration and stem cell sphere formation.
Chen L; Wang Y; Zhang B
Pathol Res Pract; 2023 Jan; 241():154224. PubMed ID: 36566599
[TBL] [Abstract][Full Text] [Related]
5. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
6. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer.
Kim JW; Kim ST; Turner AR; Young T; Smith S; Liu W; Lindberg J; Egevad L; Gronberg H; Isaacs WB; Xu J
PLoS One; 2012; 7(10):e48455. PubMed ID: 23119026
[TBL] [Abstract][Full Text] [Related]
7. PON1 hypermethylation is associated with progression of renal cell carcinoma.
Li X; Yu Q
J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
[TBL] [Abstract][Full Text] [Related]
8. PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.
Wu K; Xu L; Cheng L
Comput Math Methods Med; 2021; 2021():5542485. PubMed ID: 33968158
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
10. Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
Pan J; Chen Y; Mo C; Wang D; Chen J; Mao X; Guo S; Zhuang J; Qiu S
PLoS One; 2014; 9(3):e92815. PubMed ID: 24664224
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-mediated low expression of ZNF582 promotes the proliferation, migration, and invasion of clear cell renal cell carcinoma.
Ding M; Wang Q; Zhu W; Chang J; Liao H; Xiao G
Clin Exp Nephrol; 2023 Jan; 27(1):24-31. PubMed ID: 36129555
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
13. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of EphA5 by promoter methylation in human prostate cancer.
Li S; Zhu Y; Ma C; Qiu Z; Zhang X; Kang Z; Wu Z; Wang H; Xu X; Zhang H; Ren G; Tang J; Li X; Guan M
BMC Cancer; 2015 Jan; 15():18. PubMed ID: 25609195
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
Vantaku V; Putluri V; Bader DA; Maity S; Ma J; Arnold JM; Rajapakshe K; Donepudi SR; von Rundstedt FC; Devarakonda V; Dubrulle J; Karanam B; McGuire SE; Stossi F; Jain AK; Coarfa C; Cao Q; Sikora AG; Villanueva H; Kavuri SM; Lotan Y; Sreekumar A; Putluri N
Oncogene; 2020 Oct; 39(40):6265-6285. PubMed ID: 31383940
[TBL] [Abstract][Full Text] [Related]
17. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.
Liu J; Lin F; Wang X; Li C; Qi Q
Bioengineered; 2022 Apr; 13(4):7972-7983. PubMed ID: 35358005
[TBL] [Abstract][Full Text] [Related]
18. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
[TBL] [Abstract][Full Text] [Related]
19. TMEM130 regulates cell migration through DNA methylation in nasopharyngeal carcinoma.
Liu H; Zhang Y; Chen W; Zhang Y; Zhang W
Cancer Biomark; 2022; 34(2):265-273. PubMed ID: 34958002
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
